Celecoxib regulates apoptosis and autophagy via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer cells

International Journal of Molecular Medicine

Volumn 33, Issue 6, 2014, Pages 1451-1458

  Liu, Min ^a   Li, Chun Mei ^a   Chen, Zhao Feng ^a   Ji, Ri ^a   Guo, Qing Hong ^a   Li, Qiang ^a   Zhang, Hong Ling ^a   Zhou, Yong Ning ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Akt; Apoptosis; Autophagy; Caspase 8; Caspase 9; Celecoxib; Cyclooxygenase 2; Gastric carcinoma

Indexed keywords

CASPASE 8; CASPASE 9; CELECOXIB; DNA NUCLEOTIDYLEXOTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROCASPASE 8; PROCASPASE 9; PROTEIN KINASE B; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL; CELL PROLIFERATION; CELL STRUCTURE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MTT ASSAY; NICK END LABELING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; DRUG EFFECTS; GENETICS; METABOLISM; STOMACH TUMOR; TUMOR CELL LINE;

APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CASPASE 8; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; MICROSCOPY, ELECTRON, TRANSMISSION; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PYRAZOLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; SULFONAMIDES;

EID: 84899496876     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1713     Document Type: Article

References (37)

1. Saukkonen K, Rintahaka J, Sivula A, et al: Cyclooxygenase-2 and gastric carcinogenesis. APMIS 111: 915-925, 2003. (Pubitemid 37352608)
2. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA and Prescott SM: Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268: 9049-9054, 1993. (Pubitemid 23118701)
3. Sarkar FH, Adsule S, Li Y and Padhye S: Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy. Mini Rev Med Chem 7: 599-608, 2007. (Pubitemid 47099180)
4. Duan L, Wu AH, Sullivan-Halley J and Bernstein L: Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County. Cancer Epidemiol Biomarkers Prev 17: 126-134, 2008. (Pubitemid 351196282)
5. Fu SL, Wu YL, Zhang YP, Qiao MM and Chen Y: Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer. World J Gastroenterol 10: 1971-1974, 2004.
6. Lo AC, Woo TT, Wong RL and Wong D: Apoptosis and other cell death mechanisms after retinal detachment: implications for photoreceptor rescue. Ophthalmologica 226 (Suppl 1): 10-17, 2011.
7. Su M, Mei Y and Sinha S: Role of the crosstalk between autophagy and apoptosis in cancer. J Oncol 2013: 102735, 2013.
8. Qadri SS, Wang JH, Coffey JC, et al: Surgically induced accelerated local and distant tumor growth is significantly attenuated by selective COX-2 inhibition. Ann Thorac Surg 79: 990-995, 2005. (Pubitemid 40288763)
9. Grösch S, Maier TJ, Schiffmann S and Geisslinger G: Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 98: 736-747, 2006. (Pubitemid 43983297)
10. Baek JY, Hur W, Wang JS, Bae SH and Yoon SK: Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest. World J Gastroenterol 13: 1175-1181, 2007. (Pubitemid 46592957)
11. Jendrossek V: Targeting apoptosis pathways by celecoxib in cancer. Cancer Lett 332: 313-324, 2013.
12. Fan XM, Jiang XH, Gu Q, et al: Inhibition of Akt/PKB by a COX-2 inhibitor induces apoptosis in gastric cancer cells. Digestion 73: 75-83, 2006. (Pubitemid 44155907)
13. Kim N, Kim CH, Ahn DW, et al: Anti-gastric cancer effects of Celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling. J Gastroenterol Hepatol 24: 480-487, 2009.
14. Patru CL, Surlin V, Georgescu I and Patru E: Current issues in gastric cancer epidemiology. Rev Med Chir Soc Med Nat Iasi 117: 199-204, 2013.
15. Futagami S, Suzuki K, Hiratsuka T, et al: Chemopreventive effect of Celecoxib in gastric cancer. Inflammopharmacology 15: 1-4, 2007. (Pubitemid 46333876)
16. Willoughby DA, Moore AR and Colville-Nash PR: COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet 355: 646-648, 2000. (Pubitemid 30099478)
17. Greenhough A, Smartt HJ, Moore AE, et al: The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30: 377-386, 2009.
18. Liu Y and Liu BA: Enhanced proliferation, invasion, and epithelial-mesenchymal transition of nicotine-promoted gastric cancer by periostin. World J Gastroenterol 17: 2674-2680, 2011.
19. Fulda S: Caspase-8 in cancer biology and therapy. Cancer Lett 281: 128-133, 2009.
20. Würstle ML, Laussmann MA and Rehm M: The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome. Exp Cell Res 318: 1213-1220, 2012.
21. Allan LA and Clarke PR: Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation. FEBS J 276: 6063-6073, 2009.
22. White E, Karp C, Strohecker AM, Guo Y and Mathew R: Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol 22: 212-217, 2010.
23. Lorin S, Hamaï A, Mehrpour M and Codogno P: Autophagy regulation and its role in cancer. Semin Cancer Biol 23: 361-379, 2013.
24. White E: Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12: 401-410, 2012.
25. Helgason GV, Holyoake TL and Ryan KM: Role of autophagy in cancer prevention, development and therapy. Essays Biochem 55: 133-151, 2013.
26. Xie BS, Zhao HC, Yao SK, et al: Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells. Int J Mol Med 27: 599-606, 2011.
27. Liu B, Wu JM, Li J, et al: Polygonatum cyrtonema lectin induces murine fibrosarcoma L929 cell apoptosis and autophagy via blocking Ras-Raf and PI3K-Akt signaling pathways. Biochimie 92: 1934-1938, 2010.
28. Ye B, Jiang LL, Xu HT, Zhou DW and Li ZS: Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis. Int J Immunopathol Pharmacol 25: 627-636, 2012.
29. Lin X, Zhang X, Wang Q, et al: Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-kappaB signaling pathway in a human breast cancer cell line. Neoplasma 59: 248-256, 2012.
30. Kang XH, Xu ZY, Gong YB, et al: Bufalin reverses HGF-induced resistance to EGFR-TKIs in EGFR mutant lung cancer cells via blockage of Met/PI3k/Akt pathway and induction of apoptosis. Evid Based Complement Alternat Med 2013: 243859, 2013.
31. Chang F, Lee JT, Navolanic PM, et al: Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17: 590-603, 2003. (Pubitemid 36395654)
32. Song G, Ouyang G and Bao S: The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9: 59-71, 2005.
33. Falasca M: PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs. Curr Pharm Des 16: 1410-1416, 2010.
34. Garcia-Echeverria C and Sellers WR: Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene 27: 5511-5526, 2008.
35. Liu J, Lin Y, Yang H, Deng Q, Chen and He J: The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer. Tumor Biol 32: 1113-1121, 2011.
36. Cheng Y, Ren X, Zhang Y, et al: eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Res 71: 2654-2663, 2011.
37. Djavaheri-Mergny M, Maiuri MC and Kroemer G: Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 29: 1717-1719, 2010.